Detected ·
PlusVitech
€3M—
Biotech startup PlusVitech raised €3M with backing from CDTI and ENISA. The Seville-based company is developing PVT-01, a nanotechnology-based oncology treatment currently in Phase 1/2 clinical trials for advanced lung cancer.
- Website
- www.plusvitech.com
- Amount
- €3 000 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-03 12:09:17 UTC
- Signal ID
- 919cbcbc-d0c1-475a-b9c3-9536965b8755
As the API returns it
{
"id": "919cbcbc-d0c1-475a-b9c3-9536965b8755",
"created_at": "2026-07-03T12:09:17.725098Z",
"company_name": "PlusVitech",
"company_website_url": "www.plusvitech.com",
"company_linkedin_url": "https://www.linkedin.com/company/plusvitech-oncology-solutions",
"event_type": "funding",
"funding_amount": 3000000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*Biotech startup PlusVitech raised €3M with backing from CDTI and ENISA. The Seville-based company is developing PVT-01, a nanotechnology-based oncology treatment currently in Phase 1/2 clinical trials for advanced lung cancer.*"
}